FDA.reportPublic FDA data

Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006

RxCUI
753601
RxNorm name
Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006
Display name
Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006
Full name
Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cd6868b9-5824-442b-8d65-4db29ecb70a4Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006 [PSN] · omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension [Zegerid Reformulated Aug 2006] [SBD] · Omeprazole 40 MG / NaHCO3 1680 MG Powder for Oral Suspension [Zegerid Reformulated Aug 2006] [SY] · Zegerid (omeprazole 40 MG / sodium bicarbonate 1680 MG) Powder for Oral Suspension, Reformulated Aug 2006 [SY] · Zegerid 40 MG / 1680 MG Powder for Oral Suspension, Reformulated Aug 2006 [SY]553These highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID ® (omeprazole and sodium bicarbonate) for oral suspension ZEGERID ® (omeprazole and sodium bicarbonate) capsules, for oral use Initial U.S. Approval: 200420230719